Document Detail

Pooled HIV-1 RNA viral load testing for detection of antiretroviral treatment failure in Kenyan children.
MedLine Citation:
PMID:  23542638     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Pooled viral load (VL) testing with 2 different testing strategies was evaluated as a potential cost saving method to monitor antiretroviral therapy (ART) in HIV-infected children receiving ART in a resource-limited setting.
METHODS: Archived samples collected from 250 HIV-1-infected children on first-line ART at various time points post-ART initiation were evaluated for pooled VL testing using a minipool + algorithm strategy. Additionally, samples collected in real time from 125 children on ART were assessed for virologic failure using a minipool strategy for pooled VL testing. Virologic failure was determined as HIV-1 RNA VLs >1500 copies/mL.
RESULTS: Minipool + algorithm strategy for pooled VL testing of archived samples had estimated viral failure of 13.6%, with a relative efficiency (RE) of 23.6% (95% CI: 18.5 to 29.4), and negative predictive value of 88%. This testing strategy would have resulted in 24% fewer assays needed for a cost savings of $1180 per 100 samples. The minipool strategy for pooled VL testing of samples obtained in real time yielded an estimated 23.2% of samples with viral failure and a RE of 8.0% (95% CI: 3.9 to 14.2); however, had a minipool + algorithm pooling strategy been used, the RE would have increased to 20%.
CONCLUSIONS: The minipool + algorithm strategy for pooled VL testing to detect virologic failure in HIV-1-infected children on ART was determined to be relatively efficient in detecting virologic failure, have high negative predictive value, with substantial cost savings. Pooling strategies may be important components of cost-effect strategies to reduce rates of viral failure and resistance, thus, improving clinical outcomes.
Bhavna H Chohan; Kenneth Tapia; Michele Merkel; Arphaxad C Kariuki; Brian Khasimwa; Agatha Olago; Richard Gichohi; Elizabeth M Obimbo; Dalton C Wamalwa
Related Documents :
24319358 - Infrared thermography in the architectural field.
18345188 - Design and evaluation of a null lens for testing the optical performance of silicone in...
7142658 - A test and calibration process for microcalorimeters used as thermal power meters.
17266118 - The transmission disequilibrium test and imprinting effects test based on case-parent p...
11594498 - The use of bouts and frequencies in the evaluation of hand preferences for a coordinate...
9795878 - General population screening for infection with helicobacter pylori: a realistic option?
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of acquired immune deficiency syndromes (1999)     Volume:  63     ISSN:  1944-7884     ISO Abbreviation:  J. Acquir. Immune Defic. Syndr.     Publication Date:  2013 Jul 
Date Detail:
Created Date:  2013-06-13     Completed Date:  2013-08-29     Revised Date:  2014-07-02    
Medline Journal Info:
Nlm Unique ID:  100892005     Medline TA:  J Acquir Immune Defic Syndr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e87-93     Citation Subset:  IM; X    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-HIV Agents / therapeutic use*
Child, Preschool
Drug Resistance, Viral
HIV Infections / diagnosis,  drug therapy*,  virology
HIV-1 / drug effects,  genetics,  physiology*
RNA, Viral / analysis,  blood*
Treatment Failure
Viral Load*
Grant Support
3R01 TW007632-05S1/TW/FIC NIH HHS; 5U2GPS002182 CDC 2010-2011//PHS HHS; CCU 024513 CDC 2004-2010//PHS HHS; P30 AI027757/AI/NIAID NIH HHS; R01 D43-TW000007/TW/FIC NIH HHS; R01 TW007632/TW/FIC NIH HHS; R01 TW007632/TW/FIC NIH HHS
Reg. No./Substance:
0/Anti-HIV Agents; 0/RNA, Viral

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinf...
Next Document:  No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after disconti...